These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12955020)

  • 41. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple pituitary hormone deficiency: management of puberty for optimal auxological results.
    Stanhope R; De Luca F; Delemarre-Van de Waal HA; Liotta A; Norjavaara E; Salvatoni A; Wu F;
    J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 2():1009-14. PubMed ID: 11529397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
    Faglia G; Arosio M; Porretti S
    J Endocrinol Invest; 2000 Dec; 23(11):721-3. PubMed ID: 11194703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aromatase inhibitors in precocious puberty: rationale and experience to date.
    Eugster EA
    Treat Endocrinol; 2004; 3(3):141-51. PubMed ID: 16026110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adult height in 24 patients treated for growth hormone deficiency and early puberty.
    Adan L; Souberbielle JC; Zucker JM; Pierre-Kahn A; Kalifa C; Brauner R
    J Clin Endocrinol Metab; 1997 Jan; 82(1):229-33. PubMed ID: 8989264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA; Kamp GA; Visser-van Balen H; Mul D; Waelkens JJ; Jansen M; Verhoeven-Wind L; Delemarre-van de Waal HA; de Muinck Keizer-Schrama SM; Leusink G; Roos JC; Wit JM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1402-8. PubMed ID: 17284626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
    Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
    Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of idiopathic short stature: effects of gonadotropin-releasing hormone analogs, aromatase inhibitors and anabolic steroids.
    Dunkel L
    Horm Res Paediatr; 2011; 76 Suppl 3():27-9. PubMed ID: 21912156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of aromatase inhibitors in precocious puberty.
    Feuillan P; Merke D; Leschek EW; Cutler GB
    Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone.
    Chen YD; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2001; 42(5):291-6. PubMed ID: 11729706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Precocious puberty, Gh deficiency and obesity can affect final height in patients with myelomeningocele: comparison of males and females].
    Galluzzi F; Bindi G; Poggi G; Rossi S; Danti DA; Salti R
    Pediatr Med Chir; 1999; 21(2):73-8. PubMed ID: 10570785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
    Hibi I; Tanaka T; Tanae A; Kagawa J; Hashimoto N; Yoshizawa A; Shizume K
    J Clin Endocrinol Metab; 1989 Aug; 69(2):221-6. PubMed ID: 2526818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E; Kriström B; Jonsson B; Albertsson-Wikland K;
    BMC Endocr Disord; 2015 Dec; 15():84. PubMed ID: 26682747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study.
    Tauber M; Berro B; Delagnes V; Lounis N; Jouret B; Pienkowski C; Oliver I; Rochiccioli P
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1179-83. PubMed ID: 12629103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aromatase Inhibitor as Treatment for Severely Advanced Bone Age in Congenital Adrenal Hyperplasia: A Case Report.
    Goedegebuure WJ; Hokken-Koelega ACS
    Horm Res Paediatr; 2019; 92(3):209-213. PubMed ID: 31390647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L; Sólyom E; Lombay B; Almási A; Vámosi I
    Orv Hetil; 2012 Mar; 153(11):418-24. PubMed ID: 22390866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.